{
    "organizations": [],
    "uuid": "30df18fbecc69423b2368adb803545ae8a79914e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ucb-acquires-midazolam-nasal-spray/brief-ucb-acquires-midazolam-nasal-spray-from-proximagen-idUSASO0003LD",
    "ord_in_thread": 0,
    "title": "BRIEF-UCB Acquires Midazolam Nasal Spray From Proximagen",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 20 (Reuters) - UCB SA:\n* UCB TO EXPAND EPILEPSY PORTFOLIO WITH STRATEGIC ACQUISITION OF MIDAZOLAM NASAL SPRAY FROM PROXIMAGEN\n* UCB WILL MAKE AN UPFRONT CASH PAYMENT OF $150 MILLION * MIDAZOLAM NASAL SPRAY (USL261) COMPLETED PHASE 3 CLINICAL DEVELOPMENT AND IS READY TO BE FILED AS A NEW DRUG APPLICATION (NDA) IN 2018\n* IN ADDITION, PROXIMAGEN IS ELIGIBLE TO RECEIVE CONTINGENT PAYMENTS OF UP TO $220 MILLION BASED ON CERTAIN REGULATORY APPROVAL AND SALES-BASED MILESTONES\n* TRANSACTION IS EXPECTED TO CLOSE IN Q2 OF 2018 * USL261 ALREADY GRANTED ORPHAN DRUG AND FAST TRACK DESIGNATION BY US FDA Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-20T13:18:00.000+03:00",
    "crawled": "2018-04-21T18:05:11.123+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "ucb",
        "sa",
        "ucb",
        "expand",
        "epilepsy",
        "portfolio",
        "strategic",
        "acquisition",
        "midazolam",
        "nasal",
        "spray",
        "proximagen",
        "ucb",
        "make",
        "upfront",
        "cash",
        "payment",
        "million",
        "midazolam",
        "nasal",
        "spray",
        "usl261",
        "completed",
        "phase",
        "clinical",
        "development",
        "ready",
        "filed",
        "new",
        "drug",
        "application",
        "nda",
        "addition",
        "proximagen",
        "eligible",
        "receive",
        "contingent",
        "payment",
        "million",
        "based",
        "certain",
        "regulatory",
        "approval",
        "milestone",
        "transaction",
        "expected",
        "close",
        "q2",
        "usl261",
        "already",
        "granted",
        "orphan",
        "drug",
        "fast",
        "track",
        "designation",
        "u",
        "fda",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}